Does Frataxin Deficiency Disrupt GluR2 Trafficking in the Cerebellum via Defects in Palmitoylation?
|Sep 19 2025
Preclinical evaluation of novel targets for FRDA cardiomyopathy
|Sep 6 2025
Lipidomic profiling and analyses of Friedreich’s Ataxia iPSC-derived dorsal root ganglia sensory neurons
|Aug 4 2025
Histone H3 Enzyme Activity as a Regulator of Iron-Sulfur Cluster Stability in Friedreich’s Ataxia
|Jul 31 2025
Investigating new epigenetic repressor complexes involved in silencing the FXN locus in cells from FRDA patients
|Jul 24 2025
The N-terminus of frataxin and its role in FRDA
|Apr 24 2025
Inhibition of the TLR4 receptor prevents neuro-inflammation and degeneration in frataxin-deficient sensory neurons
|Mar 24 2025
Unraveling Epigenetic Mechanisms and Therapeutic Strategies for FXN Silencing in Friedreich’s Ataxia
|Nov 17 2024
Design and synthesis of SynGR library to probe into the role of NSD-2,3 proteins in FXN expression in FRDA
|Nov 4 2024
Understanding the Pathogenesis of Friedreich’s Ataxia by Single-Cell Integration of Gene Expression, Epigenetics and Connectivity in the Cerebellar Nuclei
|Jul 6 2024
Skeletal Muscle Fatigue and Abnormal Ca2+ Signaling in Friedreich’s Ataxia
|Jun 24 2024
Investigating microglial phenotypes and functions in the pathogenesis of Friedreich’s ataxia